0
Pipeline Programs↗
4
Active Trials↗
3
Companies Involved↗
HPV is an early-stage landscape with 0 programs across 3 companies. The most active players are KTH Biopharma, Newish Biotech (Wuxi) Co., Ltd., GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
7
clinical trials
Completed3 · 43%
Not yet recruiting2 · 29%
Recruiting2 · 29%
Clinical Trials
Trial Activity
7 trials
Topical Curcumin for HPV Related Cervical Disease
Not yet recruiting·—·Phase 2·NCT04266275·200 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)